Regeneron Pharmaceuticals Inc. (REGN) announced encouraging outcomes from the Phase 3 QUASAR trial, which evaluated the efficacy of ...
Injection 8 mg for treating macular edema due to retinal vein occlusion (RVO). This includes patients with central, branch, and hemiretinal vein occlusions. The data from this trial will support a ...
Our brain and eyes can play tricks on us—not least when it comes to the expanding hole illusion. A new computational model ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback